TY  - GEN 
AU  - Filippi, Andrea R
AU  - Dziadziuszko, Rafał
AU  - García Campelo, María del Rosario
AU  - Paoli, Jean-Baptiste
AU  - Sawyer, William
AU  - Díaz Pérez, Ignacio Esteban
PY  - 2021
SN  - 1479-6694
UR  - http://hdl.handle.net/20.500.11940/18514
AB  - Consolidation durvalumab is standard of care in patients with unresectable, stage III non-small-cell lung cancer (NSCLC) without disease progression following chemoradiotherapy (the 'PACIFIC regimen'). However, many patients with poor performance...
LA  - en
TI  - DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy
DO  - 10.2217/fon-2021-0952
KW  - CHUAC
VL  - 17
ER  -